Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma

Clinical trial NCT00039000 · COMPLETED

Trial details

NCT number: NCT00039000
Sponsor: Agenus Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2002-03-01
Primary completion: 2005-12-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.